[PPB] QoQ Cumulative Quarter Result on 31-Mar-2010 [#1]

Announcement Date
24-May-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Mar-2010 [#1]
Profit Trend
QoQ- -30.36%
YoY- 313.98%
Quarter Report
View:
Show?
Cumulative Result
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Revenue 2,274,036 1,659,256 1,084,725 503,633 2,053,769 1,550,129 1,038,953 68.33%
PBT 1,131,486 945,577 628,491 302,588 1,455,390 1,132,972 626,081 48.21%
Tax 777,740 794,696 818,516 825,325 173,649 142,503 50,463 516.23%
NP 1,909,226 1,740,273 1,447,007 1,127,913 1,629,039 1,275,475 676,544 99.32%
-
NP to SH 1,884,949 1,731,091 1,443,100 1,125,354 1,615,964 1,264,439 669,367 99.03%
-
Tax Rate -68.74% -84.04% -130.24% -272.76% -11.93% -12.58% -8.06% -
Total Cost 364,810 -81,017 -362,282 -624,280 424,730 274,654 362,409 0.43%
-
Net Worth 13,277,624 13,076,244 14,142,925 14,142,498 14,083,818 13,929,455 13,456,103 -0.88%
Dividend
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Div 1,043,241 829,861 829,844 - 865,419 59,274 59,277 573.07%
Div Payout % 55.35% 47.94% 57.50% - 53.55% 4.69% 8.86% -
Equity
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Net Worth 13,277,624 13,076,244 14,142,925 14,142,498 14,083,818 13,929,455 13,456,103 -0.88%
NOSH 1,185,502 1,185,516 1,185,492 1,185,456 1,185,506 1,185,485 1,185,559 -0.00%
Ratio Analysis
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
NP Margin 83.96% 104.88% 133.40% 223.96% 79.32% 82.28% 65.12% -
ROE 14.20% 13.24% 10.20% 7.96% 11.47% 9.08% 4.97% -
Per Share
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
RPS 191.82 139.96 91.50 42.48 173.24 130.76 87.63 68.34%
EPS 159.00 146.02 121.73 94.93 136.31 106.66 56.46 99.04%
DPS 88.00 70.00 70.00 0.00 73.00 5.00 5.00 573.08%
NAPS 11.20 11.03 11.93 11.93 11.88 11.75 11.35 -0.88%
Adjusted Per Share Value based on latest NOSH - 1,185,456
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
RPS 159.85 116.64 76.25 35.40 144.37 108.96 73.03 68.34%
EPS 132.50 121.69 101.44 79.11 113.59 88.88 47.05 99.04%
DPS 73.33 58.33 58.33 0.00 60.83 4.17 4.17 572.71%
NAPS 9.3334 9.1918 9.9416 9.9413 9.9001 9.7915 9.4588 -0.88%
Price Multiplier on Financial Quarter End Date
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Date 30/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 -
Price 17.26 17.20 15.98 18.00 15.96 15.40 11.60 -
P/RPS 9.00 12.29 17.46 42.37 9.21 11.78 13.24 -22.63%
P/EPS 10.86 11.78 13.13 18.96 11.71 14.44 20.55 -34.55%
EY 9.21 8.49 7.62 5.27 8.54 6.93 4.87 52.75%
DY 5.10 4.07 4.38 0.00 4.57 0.32 0.43 417.73%
P/NAPS 1.54 1.56 1.34 1.51 1.34 1.31 1.02 31.50%
Price Multiplier on Announcement Date
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Date 28/02/11 22/11/10 25/08/10 24/05/10 02/03/10 20/11/09 21/08/09 -
Price 16.50 18.80 16.90 16.20 16.16 15.70 15.30 -
P/RPS 8.60 13.43 18.47 38.13 9.33 12.01 17.46 -37.55%
P/EPS 10.38 12.87 13.88 17.07 11.86 14.72 27.10 -47.16%
EY 9.64 7.77 7.20 5.86 8.44 6.79 3.69 89.35%
DY 5.33 3.72 4.14 0.00 4.52 0.32 0.33 535.73%
P/NAPS 1.47 1.70 1.42 1.36 1.36 1.34 1.35 5.82%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment